NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-097-2020-0-IN-07 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE IN National Stage 202217058054 Pending
NIAID E-097-2020-0-BR-04 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE BR National Stage BR112022017512-4 Pending
NIAID E-097-2020-0-AU-03 CD28H DOMAIN-CONTAINING CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE AU National Stage 2020437669 Pending
NHLBI E-196-2017-0-US-03 POLYDOPAMINE-ENCAPSULATED NANODIAMONDS AND METHODS US National Stage 16/650,507 Abandoned
NCI E-237-2017-1-US-11 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION US National Stage 16/650,696 Pending
NCI E-084-2019-0-EP-03 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand EP National Stage 20772823.9 Pending
NCI E-084-2019-0-CN-06 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand CN National Stage 202080023309.6 Pending
NCI E-084-2019-0-PCT-02 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand PCT PCT PCT/US2020/023644 Expired
NCI E-084-2019-0-KR-07 Automated Device With Integrated Histology Tissue Sectioning, Staining, And Scanning For High Throughput Demand KR National Stage 10-2021-7033539 Pending
NCI E-231-2017-0-US-03 IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN US National Stage 16/648,369 11795235 Issued PDF
NCI E-133-2017-0-JP-04 IN VITRO GENERATION OF THYMIC ORGANOID FROM HUMAN PLURIPOTENT STEM CELLS JP National Stage 2020-516436 Issued
NCI E-104-2013-0-US-05 ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US CON 16/823,218 11512138 Issued PDF
NCI E-133-2017-0-US-05 In Vitro Generation Of An Autologous Thymic Organoid From Human Pluripotent Stem Cells US National Stage 16/648,008 11898166 Issued PDF
NCI E-099-2014-0-US-12 USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS US DIV 16/821,674 11702472 Issued PDF
NCI E-234-2014-1-KR-01 B T METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF KR DIV 10-2020-7007771 Abandoned
NCI E-210-2018-0-PCT-02 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY PCT PCT PCT/US2020/022752 Expired
NCI E-210-2018-0-CN-04 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY CN National Stage 202080021582.5 Pending
NCI E-210-2018-0-HK-05 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY HK EP 62022051308.4 Pending
NCI E-210-2018-0-EP-03 CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY EP National Stage 20718061.3 Pending
NIAID E-095-2019-0-EP-03 HIV RNA VACCINES EP National Stage 20773323.9 Pending
NIAID E-095-2019-0-PCT-02 Induction Of Protective Immunity To HIV By An MRNA-based Vaccine PCT PCT PCT/US2020/022710 Expired
NIAMS E-192-2017-0-CN-03 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF HEPATITIS B VIRUS INFECTION CN National Stage 201880059238.8 Issued
NCI E-190-2014-0-AU-45 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS AU DIV 2020201799 Issued
NCATS E-118-2019-0-CA-04 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF CA National Stage 3137870 Pending
NCATS E-118-2019-0-JP-01 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF JP National Stage 2021-563609 Pending
NCATS E-118-2019-0-PCT-02 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF PCT PCT PCT/US2020/022072 Expired
NCI E-080-2020-0-US-01 USE OF ISOVALERYLSPIRAMYCINS AS ANTI-CANCER AGENTS TO INHIBIT METASTASIS US ORD 16/816,068 Pending
NCATS E-118-2019-0-EP-03 SMALL MOLECULE BET BROMODOMAIN INHIBITORS AND USES THEREOF EP National Stage 20794764.9 Pending
NCI E-250-2014-0-US-08 ANTI-CD276 ANTIBODIES (B7H3) US DIV 16/812,980 11851498 Issued PDF
NIDDK E-081-2019-0-PC-01 Method For Improving Insulin Sensitivity PCT PCT PCT/US2020/000009 Expired
NCI E-230-2012-0-US-58 T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3 US DIV 16/812,845 Abandoned
NIDDK E-081-2019-0-EP-01 Method For Improving Insulin Sensitivity EP National Stage 20774479.8 Pending
NIDDK E-081-2019-0-KR-01 METHOD OF PRODUCING MODIFIED AMYLOID PRECURSOR PROTEIN ANCHORED WITH DETECTABLE MOIETIES AND MODIFIED AMYLOID PEPTIDES DERIVED THEREOF KR National Stage 10-2021-7033113 Pending
NIDDK E-081-2019-0-AU-01 Method of producing modified amyloid precursor protein anchored with detectable moieties and modified amyloid peptides derived thereof AU National Stage 2020239920 Pending
NIDDK E-081-2019-0-NZ-01 Method For Improving Insulin Sensitivity NZ National Stage 1978-11-09 Pending
NCI E-207-2017-1-EP-03 ADAM17 BINDING MOLECULES AND USES THEREOF EP National Stage 20769619.6 Pending
NCI E-207-2017-1-US-02 ADAM17 BINDING MOLECULES AND USES THEREOF US National Stage 17/437,065 Pending
NCI E-207-2017-1-PCT-02 ADAM17 BINDING MOLECULES AND USES THEREOF PCT PCT PCT/US2020/021603 Expired
NHLBI E-085-2019-0-PCT-01 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE PCT PCT COMB PCT/US2020/21494 Expired
NCI E-241-2016-0-US-06 Micro-Dose Calibrator US National Stage 16/644,441 11029418 Issued PDF
NCI E-040-2012-0-KR-47 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KR DIV 2020-7006131 Issued
NIA E-013-2010-0-US-16 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS US CON 16/806,659 10925840 Issued PDF
NCI E-205-2010-2-JP-19 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2020-35079 Pending
NCATS E-077-2020-2-US-01 SUBSTITUTED IMIDAZO[1,2-a]PYRIDINES AS IRAK 1/4 AND FLT3 INHIBITORS US CIP 16/804,518 Pending
NIA E-249-2016-0-HK-17 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM HK National Stage 62020003496.0 Pending
NHGRI E-149-2017-0-US-04 BIOMARKERS OF ORGANIC ACIDEMIAS US National Stage 16/641,994 11372004 Issued PDF
NCI E-238-2015-0-HK-09 MOLECULAR NANOTAGS HK CN 62020003242.8 Issued
NIAID E-236-2018-0-US-03 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof US National Stage 16/641,580 Abandoned
NCI E-234-2014-1-AU-01 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF AU DIV 2020201292 Issued
NCI E-143-2017-0-US-03 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range US National Stage 16/640,620 10994029 Issued PDF